Frol, Senta https://orcid.org/0000-0001-9494-160X
Sernec, Lana Podnar
Hudnik, Liam Korošec
Šabovič, Mišo
Oblak, Janja Pretnar
Article History
Accepted: 11 January 2021
First Online: 6 February 2021
Declarations
:
: The authors received no funding or sponsorship related to the study.
: In the past 2 years, Janja Pretnar Oblak, Mišo Šabovič, and Senta Frol have received honoraria for oral presentations from Bayer, Boehringer Ingelheim, and Pfizer. Lana Podnar Sernec and Liam Korošec Hudnik have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: The study was approved by the Republic of Slovenia National Medical Ethics Committee.
: Data and material are available from the corresponding author on reasonable request.
: The urgent treatment of patients was not influenced at any point by the inclusion into our study; patients were strictly treated according to international guidelines. Accordingly no consent was needed. All results were analyzed anonymously.
: SF and JPO contributed to the study design, data collection, data interpretation, and manuscript drafts. LSP and LKH contributed to the data collection, data interpretation, and manuscript drafts. MS contributed to the study design, data interpretation, and manuscript drafts. All authors gave their final approval for this version to be published.